APPLY NOW
Prof. Dr. HARI MOHAN SAXENA has won the SCOPUS INDEX Distinguished Lifetime Achievement of the Year Award in Immunology-2025
Home // WINNERS  //  SCOPUS INDEX CONCLAVE 2025  //  Prof. Dr. HARI MOHAN SAXENA has won the SCOPUS INDEX Distinguished Lifetime Achievement of the Year Award in Immunology-2025
Dr. H M Saxena is presently a National Level Monitor of the Deptt of Animal Husbandry & Dairying (DAHD), Ministry of Fisheries, Animal Husbandry & Dairying, Govt. of India. He has 31 years of work experience, including 24 years of experience in teaching and research and administrative experience of nearly 10 years. He has served as a full Professor of Immunology for 20 years and Head of the Veterinary Microbiology Deptt. for 4 years & 3 months at Guru Angad Dev Vety. & Animal Sciences University (GADVASU), Ludhiana. He was Director (Resident Instructions) cum Dean, Postgraduate Studies (with additional charge of Director, Veterinary Clinical Complex) at Bihar Animal Sciences University (BASU), Patna for 1 year & 2 ½ months. He was the Dean of Shekhawati Veterinary College, Sikar, Rajasthan, India for 6 months. He has served as the Counsellor (S&T) (Diplomat in the rank of Director) in the Embassy of India, Moscow, Russia (concurrently accredited to Ukraine & Belarus) for 3 yrs & 9 months. Monitored DAHD projects in Karnataka, Maharashtra & Arunachal Pradesh. Dr. Saxena is an eminent educationist and a teacher par excellence. He has been bestowed with Lifetime Education Excellence Award & Medal by AIBDA, Eminent Educationist Award by Indus Found., Hyd., Dr. S Radhakrishnan Lifetime Achievement National Award in teaching by IRDP and Dr. S. Radhakrishnan Distinguished Professor Award by CPACE. He is a scientist of international repute and was conferred National Excellence Award by LSF, India, Lifetime Achievement Award by Venus Int’l Found., Chennai, Dr. BR Ambedkar Vet for Nation Award 2025 and Distinguished Scientist Award by the World Res. Council. He has obtained patents in USA, Europe, China, South Africa and India for innovations in diagnosis. He is a Fellow of World Innovation Foundation (UK), National Academy of Veterinary Sciences (India), Indian Society for Veterinary Immunology & Biotechnology (ISVIB), Ind Assoc of Applied Microbiologists, Society for Appl Biotechnology and Society for Scientific Developments in Agri. & Technology. He has won Int’l. Paul Ehrlich Award, FM Burnet Award, Scientist Award, Mid-Career Scientist Award and Young Scientist Award Gold Medals of ISVIB and the ISHEER Award Silver Medal of the Indian Society for Health, Edu., Environment & Research, Rana Memorial Award of Assoc. of Microbiologists of India, and RRK Shukla Award of Indian Assoc. for Advanc. of Vet. Res. He was awarded Golden Door Award 2021 Gold Medal in poetry & GDA-Rex Karmaveer Chakra Award 2021 (Bronze Medal and Truth Writer Fellowship) and Rex Karmaveer Chakra Award 2023 (Global Fellowship & Medal) by International Confederation of NGOs (iCONGO) in partnership with the United Nations. Dr. Saxena is a Senior Expert of the Asia Pacific CEO Association Worldwide and was a Member of the Expert Panel on Vaccines of the European Society for Translational Medicine. He was a Member of Steering Committee of Science Advisory Board, USA and President of ISVIB. He is a Member, Advisory Board of Acta Scientific Veterinary Science, Member of Immunology Advisory Board of WebMedCentral (UK) and a Member of Immunology Editorial Board of WebMedCentral Plus, UK. He is a reviewer of Nature Scientific Reports and Nature Molecular Biology Reports, was a Review Editor of Frontiers in Immunology, and is an Editor of the Journal of Clinical Immunology and Immunopathology Research (Academic Journals, N York, USA), Member, Editorial Board of World Journal of Veterinary Science, Acta Scientific Microbiology and Indian Journal of Vety. Res. Dr. Saxena was a Member of Board of Management, Academic Council and Research Council and Chairman of PG Board of Studies of BASU and Member of Academic Council of GADVASU. He was Member Secretary of Institutional Animal Ethics Committee (IAEC) GADVASU for 5 years and is a Member, IEC, Sankara Eye Hospital. He is a Member of Expert Panels of FSSAI, Agricultural Scientists’ Recruitment Board, Union Public Service Commission, and Indian Council of Agri. Res., Veterinary Council of India and Selection Committees of 3 universities (HAU, BHU, CSKHPKVV & DUVASU). He has a first-class BVSc & AH degree, a first class MVSc degree in Veterinary Pathology from Hisar and a PhD degree in Immunology from the University of Nottingham, UK. He studied Natural Sciences Tripos part II Biology (Immunology & Cellular Pathology) at the University of Cambridge, UK and an advanced course in Immunology at the University of Tokyo, Japan. He was the Principal Investigator of five R&D projects funded by Deptt of Biotechnology (Min. of S&T), University Grants Commission (1 each) and Rashtriya Krishi Vikas Yojana (3), respectively. Three books written / edited by him have been published (1 book was translated in 6 foreign languages). He has published 109 original research papers, 21 chapters in books, 4 manuals, 16 chapters in manuals, 28 articles & 45 issues of a scientific bulletin and presented 76 papers (3 keynote addresses & 10 lead papers in international and 2 keynote addresses & 9 lead papers in national conferences), chaired sessions at 3 international & 8 national conferences & guided 1 PhD &10 MVSc students. My major scientific contributions in Immunology and infectious diseases Brucellosis is the second most important zoonotic disease affecting domestic animals like cattle, buffaloes, sheep, goats, pigs, dogs, camels etc and can be spread from animals to humans. The disease causes abortion, hygroma, orchitis and reproductive disorders in farm animals and pain and discomfort in humans. It causes huge economic losses worldwide including Rs. 20,000 Crores annual losses in India. The available antibiotics are not effective and there is no cure for this disease presently anywhere in the world. The animals once infected become carriers of infection and keep spreading it during their lifetime infecting other animals. The vaccine presently used in India has not been successful in controlling the disease and the infection is spreading in the country at an alarming rate endangering the herds of high yielding elite indigenous breeds of cattle and buffaloes. I have developed a novel immunotherapy for bovine Brucellosis in which a single subcutaneous injection of 2 ml of phage lysates (bacteria killed with a bacteriophage) of Brucella abortus strains S19 and RB51 can cure Brucellosis in adult cows in 3 months. This is a major breakthrough in non-antibiotic treatment of important bacterial diseases. I have also identified for the first time in the world a new simple method for specific and accurate non-invasive monitoring and assessment of the effect of antibacterial therapy in Brucellosis employing a pathogen – specific biomarker (Brucella – specific RNA in the blood plasma). The same principle is applicable to other bacterial diseases (e.g., TB) also. Hitherto, a destructive way of determining the effect of new antibacterial therapies was used worldwide where animals were sacrificed and their organs were harvested for estimating the bacterial load without and after the treatment. The new method developed by me can be a game changer in developing new antibiotics and other antibacterial therapies in view of the impending global pandemic of antimicrobial resistance by real time monitoring and assessment of new antibacterial therapies on patients without the need of sacrificing experimental animals thus saving precious lives, time and huge money spent on traditional methods of evaluation. I have also pioneered Bacteriophage therapy of Brucellosis in cattle for the first time in the world. This is useful in cases of antibiotic resistant infections. The diagnostic test for Brucellosis presently used worldwide can give false positive and false negative tests which affect the farm economy as false negative animals escape treatment and continue to spread the disease. False positive animals are culled even if they don’t have the disease. I have developed a new Superagglutination test for diagnosis of Brucellosis which is more accurate and removes false results in diagnosis. The principle is applicable to hundreds of other bacterial diseases where agglutination test is used for diagnosis.